Chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: a retrospective cohort study

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter Y. Maruki
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors Y. Maruki1, H. Ueno2, M. Sasaki2, Y. Sakamoto2, S. Kondo2, C. Morizane2, Y. Ito3, T. Okusaka2
  • 1National Cancer Center Hospital, Chuo-ku, Japan, /
  • 2Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Japan, /
  • 3Department of Radiation Therapy, National Cancer Center Hospital, Chuo-ku, Japan, /

Abstract

The optimal treatment strategy for locally advanced pancreatic cancer (LAPC) is still controversial, and the role of local control by chemoradiotherapy (CRT) has not been established. The aim of this retrospective analysis was to compare the long-term outcome of patients (pts) with LAPC treated with CRT or chemotherapy (C) alone.